Loading...
ROCO
6493
Market cap32mUSD
Oct 08, Last price  
34.95TWD
1D
0.14%
1Q
-32.79%
Jan 2017
23.59%
IPO
-18.15%
Name

TTBIO Corp

Chart & performance

D1W1MN
ROCO:6493 chart
P/E
—
P/S
2.63
EPS
—
Div yield, %
0.57%
Shrs. gr., 5y
2.29%
Rev. gr., 5y
17.39%
Revenues
399m
+27.80%
267,086,000178,957,000305,517,000418,882,000318,089,000312,116,000398,880,000
Net income
-21m
L
37,990,00045,878,00011,533,00039,796,0006,677,0002,590,000-21,300,000
CFO
-41m
L
73,608,000-3,189,00047,126,00050,112,0003,995,00025,352,000-41,010,000
Dividend
Jul 28, 20250.20008 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ttbio Corp. specializes in the development, distribution, and after-sales support of medical devices under its proprietary TTBIO brand, serving both the Taiwanese domestic market and a global clientele. Its product offerings include a range of high-speed and low-speed dental handpieces, alongside essential dental spare components, service rotors, maintenance systems, and advanced electric handpiece solutions. Beyond its core medical device portfolio, Ttbio is also a key supplier of high-precision machined parts and custom components. These are engineered to cater to diverse sectors such as automotive, aerospace, security, and computing hardware, in addition to providing parts for general industrial maintenance and specialized custom projects. Established in 2012, Ttbio Corp. maintains its headquarters in Taichung, Taiwan.

Key people

Jialing Wang
Deputy Manager-Finance Division · since 2014
Xin Zhuang
Head of Finance & Accounting · since 2025
Chairman of the Board · since 2018
Jingliang Chen
Director · since 2018
Yiting Huang
Director · since 2013
Wangzheng Ke
Director
Director
Zhengfang Su
Director · since 2015
General Manager, Director · since 2015
Huiyi Wu
Director · since 2013
Meihong Zhang
Director · since 2013
Fengning Zhang
Director · since 2025
Y.C. Wu
Independent Director · since 2022
Wei'en Wu
Independent Director · since 2022
IPO date
Jan 08, 2015
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT